MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

AVE3085

CAS No. : 450348-85-3

MCE 站：AVE3085

产品活性：AVE3085 是一种有效的 nitric oxide synthase 增强剂，常用于心血管疾病的研究。

研究领域：Immunology/Inflammation

作用靶点：NO Synthase

In Vitro: Pre-incubation with AVE3085 restores the bradykinin-induced relaxation, reverses the decrease of p-eNOS^Ser1177, and loares the level of p-eNOS^Thr495 and nitrotyrosine. NO release in response to bradykinin is significantly reduced by ADMA and such reduction is restored by AVE3085. AVE3085 also prevents the elevation of O₂^.? and ONOO^? levels in coronary arteries exposed to ADMA. AVE3085 (10 μM) markedly increases ACh-induced relaxations in SHR aortae without affecting those in WKY aortae, and also increases the eNOS expression in WKY aortae.

In Vivo: AVE3085 (10 mg/kg/day, p.o.) treatment prevents the increases in the left ventricular weight, left ventricular weight/body weight ratio, mean myocyte diameter, and the expression of the hypertrophic markers ANP and β-MHC compared to the vehicle-treated mice. AVE 3085 treatment also attenuates the collagen volume fraction levels compared to the vehicle-treated mice. In the AVE3085-treated mice, the EFs, FSs, mitral E velocity, E/A ratio and LVDds are significantly improved compared to the vehicle-treated mice. AVE 3085 treatment attenuates the increase in the expression of Smad2 mRNA. Furthermore, the levels of the eNOS protein expression are significantly up-regulated in the AVE3085 group than in the vehicle-treated AB group. AVE3085 (10 mg/kg, p.o.) significantly improves ACh-induced endothelium-dependent relaxations in the aortae of SHRs, and reduces systolic blood pressure in SHRs. AVE3085 treatment for 4 weeks increases levels of p-eNOS and eNOS in SHR aortae without affecting levels of eNOS and p-eNOS in WKY aortae.

相关产品：Bioactive Compound Library Plus  |  Immunology/Inflammation Compound Library  |  Anti-Aging Compound Library  |  Anti-Cardiovascular Disease Compound Library  |  Mifepristone  |  L-NAME hydrochloride  |  L-NMMA acetate  |  1400W Dihydrochloride  |  L-Arginine  |  S-Nitroso-N-acetyl-DL-penicillamine  |  Methylene Blue  |  Asymmetric dimethylarginine  |  Isoquercetin  |  Chondroitin sulfate  |  L-NIL  |  Tetrahydrobiopterin  |  2,4-Diamino-6-hydroxypyrimidine  |  Ginsenoside C-K  |  6-Biopterin  |  Agmatine sulfate  |  GW274150  |  Isosorbide dinitrate  |  L-NIO dihydrochloride  |  Pectolinarin  |  L-Canavanine sulfate  |  Ginsenoside Rb3  |  Madecassic acid  |  NOC 18  |  TP508 TFA  |  Irisflorentin  |  Prim-O-glucosylcimifugin  |  Harpagoside

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。